Acumen Pharmaceuticals (ABOS) Enterprise Value (2020 - 2026)
Acumen Pharmaceuticals recorded quarterly Enterprise Value of -$128.4 million in Q1 2026, down 9.87% quarter-over-quarter from -$116.9 million in Q4 2025, and up 13.91% year-over-year from -$112.7 million in Q1 2025.
Acumen Pharmaceuticals' Enterprise Value history runs 7 years deep, the most recent figure standing at -$128.4 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 13.91% year-over-year to -$128.4 million; the TTM figure through Mar 2026 stood at -$128.4 million (up 13.91% YoY), while the FY2025 annual figure was -$116.9 million, up 31.75% from the prior year.
- Enterprise Value came in at -$128.4 million for Q1 2026 at Acumen Pharmaceuticals, down from -$116.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$116.9 million in Q4 2025 to a low of -$260.1 million in Q2 2024.
- A 5-year average of -$179.3 million and a median of -$176.6 million in 2022 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 175.99% in 2022 and surged 44.88% in 2025, its largest moves.
- Acumen Pharmaceuticals' Enterprise Value stood at -$176.6 million in 2022, then sank by 37.5% to -$242.8 million in 2023, then increased by 29.49% to -$171.2 million in 2024, then soared by 31.75% to -$116.9 million in 2025, then dropped by 9.87% to -$128.4 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$128.4 million, -$116.9 million, and -$126.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - | -128.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.40 Mn |
| Dec 31, 2025 | -116.87 Mn |
| Sep 30, 2025 | -126.61 Mn |
| Jun 30, 2025 | -143.37 Mn |
| Mar 31, 2025 | -149.15 Mn |
| Dec 31, 2024 | -171.23 Mn |
| Sep 30, 2024 | -200.34 Mn |
| Jun 30, 2024 | -260.12 Mn |
| Mar 31, 2024 | -252.51 Mn |
| Dec 31, 2023 | -242.84 Mn |
| Sep 30, 2023 | -215.43 Mn |
| Jun 30, 2023 | -144.88 Mn |
| Mar 31, 2023 | -140.41 Mn |
| Dec 31, 2022 | -176.60 Mn |
| Sep 30, 2022 | -200.19 Mn |
| Jun 30, 2022 | -189.91 Mn |
| Mar 31, 2022 | -189.09 Mn |
| Dec 31, 2021 | -194.24 Mn |
| Sep 30, 2021 | -199.96 Mn |
| Jun 30, 2021 | -68.81 Mn |
| Dec 31, 2020 | -43.78 Mn |
| Sep 30, 2020 | -1.96 Mn |
| Jun 30, 2020 | -3.24 Mn |